ANI Pharmaceuticals Inc

NASDAQ:ANIP  
31.57
+1.90 (+6.40%)
Earnings Announcements, Equity Financing / Related

ANI Pharmaceuticals Announces Consolidation Of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition

Published: 06/02/2022 20:11 GMT
ANI Pharmaceuticals Inc (ANIP) - Ani Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition.
Ani Pharmaceuticals Inc - Operations at Oakville, Canada Manufacturing Plant Expected to End by Q1 2023.
Ani Pharmaceuticals Inc - Intends to Cease Operations at Its Oakville, Ontario, Canada Manufacturing Plant by Q1 2023.
Ani Pharmaceuticals Inc - Expects Action to Improve Profitability and Cash Flow by $7 Million to $8 Million on an Annualized Basis.
Revenue is expected to be $71.43 Million
Adjusted EPS is expected to be $0.24

Next Quarter Revenue Guidance is expected to be $78.4 Million
Next Quarter EPS Guidance is expected to be $0.49

More details on our Analysts Page.